SIBROTUZUMAB
UNII 552U6E1NIW

Substance Identification & Data

This profile provides standardized clinical and technical data for Sibrotuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 552U6E1NIW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 216669-97-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
552U6E1NIW
CAS Registry Number
216669-97-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SIBROTUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C156438
National Cancer Institute reference terminology for clinical and research data.
INN ID
7866
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sibrotuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SIBROTUZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN FAP (FIBROBLAST ACTIVATION PROTEIN)) (HUMAN-MOUSE MONOCLONAL BIBH1 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL BIBH1 .KAPPA.-CHAIN, DIMER
SIBROTUZUMAB [INN]
SIBROTUZUMAB [WHO-DD]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus